Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Protein and Gene Expression Biomarkers of Tamoxifen and Letrozole Recurrence in the NCIC CTG MA.17 Cohort

NCT00897065 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00897065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00897065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Protein and Gene Expression Biomarkers of Tamoxifen and Letrozole Recurrence in the NCIC CTG MA.17 Cohort
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2006
Completion date
Not reported
Enrollment
957 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer